Immune Mechanisms in Parkinson's Disease and Epilepsy. Preclinical Findings and Clinical Perspectives.

Filip Fredlund

Immune Mechanisms in Parkinson's Disease and Epilepsy. Preclinical Findings and Clinical Perspectives.

Research output: Thesis › Doctoral Thesis (compilation)

67 Downloads (Pure)

Original language	English
Qualification	Doctor
Awarding Institution	Department of Experimental Medical Science
Supervisors/Advisors	Swanberg, Maria, Supervisor Ekdahl Clementson, Christine, Assistant supervisor
Award date	2024 Sept 19
Place of Publication	Lund
Publisher	Lund University, Faculty of Medicine
ISBN (Print)	978-91-8021-600-5
Publication status	Published - 2024

Bibliographical note

Defence details
Date: 2024-09-19
Time: 09:00
Place: Belfragesalen, BMC D15, Klinikgatan 32 i Lund
External reviewer(s)
Name: Harms, Ashley
Title: Associate Professor
Affiliation: University of Alabama at Birmingham, Alabama, USA

Subject classification (UKÄ)

Medical and Health Sciences
Neurosciences

Free keywords

Immune mechanisms
Parkinson's disease
α-syn
Ciita
TNF
epilepsy
Syn2
IL-6

Access to Document

Filip Fredlund - ThesisFinal published version, 11.9 MB

3 Article

Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson’s Disease
Fredlund, F., Jimenez-Ferrer, I., Grabert, K., Belfiori, L., Luk, K. C. & Swanberg, M., 2024, In: Journal of Parkinson's Disease. 14, 4
Research output: Contribution to journal › Article › peer-review

Open Access
Reduced epilepsy development in synapsin 2 knockout mice with autistic behavior following early systemic treatment with interleukin-6 receptor antibody
Bäckström, F., Ahl, M., Wickham, J. & Ekdahl, C. T., 2023, In: Epilepsy Research. 191, 107114.
Research output: Contribution to journal › Article › peer-review

Open Access
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
Jimenez-Ferrer, I., Bäckström, F., Dueñas-Rey, A., Jewett, M., Boza-Serrano, A., Luk, K. C., Deierborg, T. & Swanberg, M., 2021 Jan, In: Brain, Behavior, and Immunity. 91, p. 369-382 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access

Cite this

@phdthesis{bbfa40a9b1fd4a2c8a7d021783e373bb,

title = "Immune Mechanisms in Parkinson's Disease and Epilepsy. Preclinical Findings and Clinical Perspectives.",

keywords = "Immune mechanisms, Parkinson's disease, α-syn, Ciita, TNF, epilepsy, Syn2, IL-6",

author = "Filip Fredlund",

note = "Defence details Date: 2024-09-19 Time: 09:00 Place: Belfragesalen, BMC D15, Klinikgatan 32 i Lund External reviewer(s) Name: Harms, Ashley Title: Associate Professor Affiliation: University of Alabama at Birmingham, Alabama, USA",

year = "2024",

language = "English",

isbn = "978-91-8021-600-5",

series = "Lund University, Faculty of Medicine Doctoral Dissertation Series",

publisher = "Lund University, Faculty of Medicine",

number = "2024:104",

type = "Doctoral Thesis (compilation)",

school = "Department of Experimental Medical Science",

}

TY - THES

T1 - Immune Mechanisms in Parkinson's Disease and Epilepsy. Preclinical Findings and Clinical Perspectives.

AU - Fredlund, Filip

N1 - Defence details Date: 2024-09-19 Time: 09:00 Place: Belfragesalen, BMC D15, Klinikgatan 32 i Lund External reviewer(s) Name: Harms, Ashley Title: Associate Professor Affiliation: University of Alabama at Birmingham, Alabama, USA

PY - 2024

Y1 - 2024

KW - Immune mechanisms

KW - Parkinson's disease

KW - α-syn

KW - Ciita

KW - TNF

KW - epilepsy

KW - Syn2

KW - IL-6

M3 - Doctoral Thesis (compilation)

SN - 978-91-8021-600-5

T3 - Lund University, Faculty of Medicine Doctoral Dissertation Series

PB - Lund University, Faculty of Medicine

CY - Lund

ER -

Immune Mechanisms in Parkinson's Disease and Epilepsy. Preclinical Findings and Clinical Perspectives.

Bibliographical note

Subject classification (UKÄ)

Free keywords

Access to Document

Research output

Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson’s Disease

Reduced epilepsy development in synapsin 2 knockout mice with autistic behavior following early systemic treatment with interleukin-6 receptor antibody

The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease

Cite this